laitimes

Hong Kong stocks are | Celeess Pharma-B (01672) afternoon diving fell more than 9% in the month still accumulated more than 90% amplitude throughout the day to reach 17%

author:Zhitong Finance

Zhitong Finance APP learned that the stock price of Geli Pharmaceutical-B (01672) has continued to climb recently, rising by more than 90% in the month. The stock retreated after surging more than 5% higher in early trading, and suddenly dived in the afternoon, with a decline of more than 9% at one point. As of press time, it fell 7.92% to HK$6.28, with a turnover of HK$234 million.

On the news side, Geli Pharmaceutical announced that Laos Phokam Pharmaceutical Import-Export Co., Ltd (buyer) and the company's wholly-owned subsidiary Celees Pharmaceutical (Zhejiang) Co., Ltd. (seller) signed a purchase agreement for ritonavir tablets. Ritonavir oral tablets are pharmacokinetic enhancers of multiple oral antiviral drugs against viral proteases. The company announced on January 3 that the annual production capacity of ritonavir oral tablets has been expanded to 100 million tablets, and can be further expanded rapidly according to market demand in the future.

Read on